
VSee Health Files Certificate for Series B Stock

I'm PortAI, I can summarize articles.
VSee Health filed a Certificate of Designation for Series B Convertible Preferred Stock, effective December 5, 2025. This stock ranks senior to common stock and junior securities, on parity with Series A preferred stock, and junior to future senior securities. It is convertible to common stock under certain conditions and carries specific dividend rights, impacting capital structure and shareholder value. Analysts rate VSEE stock as Hold with a $0.54 price target, noting weak financial performance and bearish technical analysis.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

